9 terminated. 9 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Terminated 9 |
| Phase 3 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Cholangitis: new trials by email Literature Review of Cholangitis trials Research Report on Cholangitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis Ritivixibat - Primary Sclerosing Cholangitis | Phase 2 | Terminated | Albireo, an Ipsen Company | 18 | 2023-01-09 | 2026-05-04 |
| Vancomycin for Primary Sclerosing Cholangitis Vancomycin, Placebo - Primary Sclerosing Cholangitis | Phase 2 / Phase 3 | Terminated | Elizabeth Carey | 102 | 2020-01-23 | 2026-10-21 |
| A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC Seladelpar, Placebo to match Seladelpar - Primary Sclerosing Cholangitis | Phase 2 | Terminated | Gilead Sciences | 1 | 2019-11-12 | 2025-01-16 |
| An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis All-trans retinoic acid - Cholangitis, Sclerosing | Phase 2 | Terminated | Yale University | 2 | 2018-05-29 | 2021-08-09 |
| A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC) DUR-928 - Primary Sclerosing Cholangitis | Phase 2 | Terminated | Durect | 5 | 2018-01-22 | 2022-10-17 |
| Haemodynamic Stability of Ketamine/Propofol Admixture "Ketofol" in Patient Undergoing Endoscopic Retrograde Cholangio Pancreatography Ketamine / Propofol Admixture, Propofol - Pancreatitis, Cholangitis | Phase 2 | Terminated | Assiut University | 90 | 2015-07-01 | 2019-09-23 |
| Pilot Study of Fenofibrate for PSC fenofibrate - Primary Sclerosing Cholangitis | Phase 1 / Phase 2 | Terminated | University of Miami | 8 | 2010-10-01 | 2018-02-06 |
| Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC) Thalidomide - Primary Sclerosing Cholangitis | Phase 2 | Terminated | Mayo Clinic | 1 | 2006-04-01 | 2012-02-27 |
| Trial of High-dose Urso in Primary Sclerosing Cholangitis Ursodeoxycholic Acid, Placebo - Primary Sclerosing Cholangitis | Phase 2 / Phase 3 | Terminated | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 150 | 2002-07-01 | 2021-05-03 |
Cholangitis, Sclerosing (8) · Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Digestive System Diseases (1) · Pancreatitis (1)
Bile Duct Diseases (8) · Biliary Tract Diseases (8) · Digestive System Diseases (8) · Pancreatic Diseases (1)
(2-methyl-4-(5-methyl-2-(4-trifluoromethyl-phenyl)-2H-(1,2,3)triazol-4-ylmethylsulfanyl)phenoxy)acetic acid (1) · Fenofibrate (1) · Ketamine (1) · Propofol (1) · Thalidomide (1) · Tretinoin (1) · Ursodeoxycholic Acid (1) · Vancomycin (1) · seladelpar (1)
Albireo, an Ipsen Company (1) · Assiut University (1) · Durect (1) · Elizabeth Carey (1) · Gilead Sciences (1) · Mayo Clinic (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · University of Miami (1) · Yale University (1)
United States (7) · Poland (2) · Canada (1) · Egypt (1) · France (1) · Italy (1) · Spain (1)
Alastair Smith, MD (1) · Cynthia Levy, MD (1) · Elizabeth Carey, MD (1) · James Boyer, MD (1) · Keith D Lindor, MD (1) · Mohamed A Bakr, Prof. (1)
2019 (1), R01DK056924 (1)